MediTox s.r.o.

Main activities

Non clinical R & D related to ophthalmic diseases (chronic glaucoma), osteoarthritis (ACLT, CCLT, dogs, rabbits), non-clinical development of vaccines (influenza, adenovirus, etc.).

Comprehensive non-clinical and toxicological program for assessment of human/veterinary drugs, vaccines, biological products, medical devices and food/feed additives (EMA/ICH/VICH/FDA/ISO), chemical substances and preparations (ECHA)

Models of selected human diseases - chronic glaucoma, contact dermatitis, osteoarthritis, human influenza, periodontitis

Accredited breeding facility (CZ 02396)

MediTox s.r.o.

MediTox s.r.o. is a GLP-certified preclinical contract research organization offering a wide range of preclinical development services taking advantage of wealth of experience in variety of therapeutics areas, biotechnology, chemical and agrochemical industry and research collaboration with universities and research institutions.

MediTox R&D activities are pointed to collaborative scientific and research projects within international and national framework.

The strong points of MediTox ensure personalized and comprehensive contract research (one-stop-shop), high professional standard together with flexibility and competitive pricing.

We will attend following events:

Swiss Biotech Day, April 22 – 23, 2024 Basel

Swiss Bio Tech Day 2024

BIO International Convention, June 3 – 6, 2024 San Diego

BIO International Convention

Nordic Life Science Days, September 17 – 19, 2024, Malmő

Nordic Life Science Days

BIO-EUROPE, November 4 – 6, 2024, Stockholm


MediTox s.r.o.

MediTox s.r.o.

MediTox s.r.o.